Hu, X., Moisan, J., Majchrzak, K., Lesch, C., Wang, Y., Sanchez, B., . . . Carter, L. (2015). RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity. J Immunother Cancer.
Chicago Style aipamenaHu, Xiao, et al. "RORgamma Agonists Enhance Survival and Memory of Type 17 T Cells and Improve Anti-tumor Activity." J Immunother Cancer 2015.
MLA aipamenaHu, Xiao, et al. "RORgamma Agonists Enhance Survival and Memory of Type 17 T Cells and Improve Anti-tumor Activity." J Immunother Cancer 2015.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.